Halaman 14 - CT (computed tomography) - tomografi terkomputasi Dokter Terbaik - TOP-623 dokter

Experience

On his return from London, he organized and directed the Arrhythmia Unit of the Cardiology Service of the University Hospital Nuestra Señora del Pino in Las Palmas until 2000.

He later became Deputy Director of the Arrhythmia Department and Director of the Electrophysiology Laboratory at the Jimenez Diaz Foundation in Madrid.

Professor of Cardiology at the Autonomous University and Director of the North American Society of Pacing and Electrophysiology (Heart Rhythm Society) Fellowship Program, positions he held for 6 years before moving to the Quironsalud University Hospital of Madrid in 2006.

Dr. Cabrera has been head of the cardiology department at the Quironsalud University Hospital of Madrid since its opening in 2006.

Since January 2013, he has also been Head of the Cardiology Department at the Ruber Juan Bravo Hospital Complex and, in 2022, Head of Service at the new Olimpia Center.

He is a professor at the European University of Madrid, where he heads the Department of Clinical and Fundamental Translational Cardiology.

Qualification

Doctorate in Medicine and Surgery from the Faculty of Medicine of the University of Granada. From 1994 to 1996 he completed postgraduate training as an interventional cardiologist in the Arrhythmia Unit (Cardiac Electrophysiology Laboratory) of the Jiménez Díaz Foundation in Madrid.

Senior Research Fellow. National Heart and Lung Institute. Royal Brompton. Paediatric Heart Morphology under the direction of Prof. Robert H. Anderson in London (UK) in 1997.

Research and Teaching

Member of the Spanish Society of Cardiology, SEC Arrhythmia Section, European Society of Cardiology, Arrhythmia Working Group, European Heart Rhythm Association, North American Society of Pacing and Electrophysiology.

He serves on numerous committees for the selection and monitoring of fellowships and research projects of various national and international cardiology and cardiac arrhythmia societies.

Reviewer of articles for publication in the most relevant journals in the specialty. Journal of the Spanish Society of Cardiology, Heart Rhythm, Journal of Cardiovascular Electrophysiology, PACE, Europace, Heart Circulation, Journal of the American College of Cardiology, Electrophysiology of Circulation, Journal of Interventional Cardiovascular Electrophysiology.

Member of the European Society of Cardiology

Member of the Arrhythmia Working Group

European Society of Cardiology

Member of the Arrhythmia Section of the Spanish Society of Cardiology.

Member of the European Society of Cardiology (FESC)

Member of the European Heart Rhythm Association.

Member of the Selection and Control Committee of the Spanish Society of Cardiology. Post-Residency Research Training Fellowships 2001-2002/2002-2003.

Evaluator and member of the selection committee for research, technological development and innovation projects of the Government of Extremadura. Ministry of Education, Science and Technology (2001-2004).

Member of the Spanish research group. Integrated Action Programme between Spain and the United Kingdom. Directorate General of Higher Education and Research (reference HB 1998-0030). Project title: Anatomical study of the cavities of the human heart and its application to clinical electrophysiology.

Member of the Spanish research group. Integrated Action Programme between Spain and Austria. Directorate General for Higher Education and Research (reference HU 1999-0002). Project title: Electromorphological analysis of the terminal crest and posterior pectineus muscle. Its importance as a morphological substrate in different types of supraventricular tachycardias.

Participation in the clinical commission and protocol of the study AZIMILIDE versus SOTALOL on programmed cardioversion in patients with atrial fibrillation. 2001-2003.

Dr. Javier Albiñana Silveti is a specialist in orthopedic surgery and pediatric traumatology. He has over 38 years of experience in the treatment of hip dysplasia, bone tumors, malformations and Perthes disease.

Experience

2013 – present | Pediatric Traumatology at the Ruber Internacional and Quirón Hospital in Pozuelo.

2004-2013|Head of the Department of Pediatric Orthopedics at the La Paz Hospital in Madrid.

1994-2004| Assistant in pediatric orthopedics at the Niño Jesus Hospital in Madrid

1992-1994 | Fellow, Department of Pediatric Orthopedics, University of Iowa (USA)

1988-1989|Research Fellow in Paediatric Orthopaedics, Oxford University (UK).

Qualification

1988 | Doctor of Medicine, Autonomous University of Madrid.

1982 | Graduated from the Faculty of Medicine of the Autonomous University of Madrid.

Education:

2004|Associate Professor of the Faculty of Medicine of the UAM.

Publications

2019|Does femoral head orientation influence acetabular development? An experimental study in Lamb. J Pediatr Orthop. 2019 Sep;39(8):416–421.

2015|Pavlik harness outcomes in Ortolani-positive hips: predictors of failure and arthrographic findings. J Child Orthop 2015 Aug;9(4):249-53.

2013|Selective triradiate epiphysiodesis for the treatment of residual experimental acetabular dysplasia. J Pediatr Orthop. 2013 Dec;33(8):821-8.

Communications and presentations

2021|Perthes Disease. Congress of Pediatric Orthopedics, SEOT, Ecuador.

2019|Dysplasia of the hip, Children's Hospital, San Jose, Costa Rica, April 2019

2018| Cerebral Palsy, ASFAPE, Madrid.

2007 | Tear and Dysplasia of the Hip, POSNA, San Diego.

2005 | Open reduction failure and DDH. Boston, IPOTT.

Education and Specialization:

• Medical Degree: Gazi University Faculty of Medicine (2010)
• Specialization in Orthopedics and Traumatology: S.B. Dışkapı Yıldırım Beyazıt Training and Research Hospital (2017)

Professional Experience:

• Current Position: Orthopedics and Traumatology Specialist at VM Medical Park Pendik Hospital, Istanbul

Areas of Expertise:

• Arthroplasty
• Arthroscopic Joint Surgery
• Trauma Surgery
• Spine Diseases and Surgery
• Tendon Injuries and Repairs
• Extremity Lengthening
• Sports Injuries
• Pediatric Orthopedics

Professional Memberships:

• Turkish Orthopedics and Traumatology Association (TOTBID)
• Turkish Medical Association

Patient Testimonials: Patients have praised Dr. Kasman for his expertise and compassionate care. They highlight his ability to provide thorough explanations and his dedication to patient recovery, making him a highly recommended specialist in his field.

Professional experience

Since 2006, he has been Head of the Neurology Department at the Quironsalud University Hospital of Madrid and the Ruber Juan Bravo Hospital.

Professor of Medicine at the Faculty of Biomedical Sciences of the European University of Madrid, holds the national accreditation of Professor of Medical Sciences (issued by ANECA).

Doctor of Medicine, Complutense University of Madrid (UCM). Award for Outstanding Doctoral Thesis (UCM, 2004): Study on the relationship of human herpes virus 6 as an environmental factor in multiple sclerosis.

Membership in scientific societies

National and International Principal Investigator in Neuroscience at Quironsalud Madrid (June 2015 – present)

President of the Research Committee of the Quironsalud University Hospital of Madrid (2012 to present).

Member of the Research Committee of the San Carlos Clinical Hospital (2012-2015).

Member of the Council of the Faculty of Medicine of the Complutense University of Madrid (2011-2015).

Research and Teaching

Principal investigator of 100 national and international clinical trials.

7 FIS research projects from the Carlos III Institute of Health (the last 5 as principal investigator).

10 projects from private foundations, received on a competitive basis (7 as principal investigator).

He has authored 139 international articles with a total impact factor of 949,917 and 4,552 citations. 38 books and book chapters with an H-factor of 34 (2018).

His publications stand out in journals that have the greatest global impact on research, such as the New England Journal of Medicine and the Lancet.

Dr. Rafael Arroyo has given over 300 international and national presentations at various Congresses.

Education :

Professor of Medicine at the Faculty of Biomedical Sciences of the European University of Madrid and holds the national accreditation of Professor of Medical Sciences (issued by ANECA).

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Professional experience

• 2018 – present : Head of the Traumatology Department at the International Orthopaedic Center Hospital Ruber Internacional in Madrid.
• 2000 – 2018 : Specialist in Hip and Knee Surgery at the International Center Hospital Ruber Internacional, Madrid.
• Until 2000 : Deputy Head of the Traumatology Department at the Hospital J. Puerta de Hierro, Madrid.

Education and qualifications

• 1992 : Medical degree from the Faculty of Medicine and Surgery of the Autonomous University of Madrid.
• Specialization in Orthopedic Surgery and Traumatology at the Puerta de Hierro Hospital.

Scientific research and clinical trials

1. Phase 2B : Efficacy and safety study of PD 0348292 for the prevention of venous thromboembolic events (VTE) in patients undergoing total knee arthroplasty.
2. CV185-047 : Comparison of the efficacy of apixaban and enoxaparin for the prevention of VTE.
3. CV185-035 : A study of prevention of deep vein thrombosis after hip replacement.
4. PRADAXA® 1160.85 : A study of the efficacy of dabigatran etexilate for the prevention of VTE following hip and knee surgery.
5. PRADAXA® 1160.84 : Evaluation of the safety of dabigatran in patients with moderate renal impairment after total renal arthroplasty.

Learning and Teaching

• 1997–2000 : Associate Professor, Department of Traumatology, Puerta de Hierro Hospital, Madrid.

Specialization and innovation

• Knee replacement : Using the latest generation navigation systems, Rapid Recovery and ERAS protocols for accelerated recovery.
• Hip Replacement : Minimally Invasive Techniques and Improved Restorative Protocols.
• Arthroscopic surgery : Treatment of diseases of the knee and hip joints.
• Non-surgical treatment : Introduction of innovative infiltration techniques for joint pathology.

Recognition and achievements

• 2022 : Included in the Forbes list as one of the 100 best doctors in Spain , recognized for leadership and innovation in joint surgery using navigation technologies.
• Since 2008 : ISO 9001:2008 certification for quality of hip and knee replacement surgeries.

Membership in professional organizations

• International Member of the American Academy of Orthopaedic Surgeons .
• Member of the Spanish Association of Arthroscopy .

The doctor has established himself as a pioneer in the field of joint surgery, introducing innovative technologies such as navigation systems and minimally invasive approaches. His achievements and approach to patient recovery make him one of the leading specialists in Spain.

Education:

Bachelor's Degree

• Field: Faculty of Medicine
• University: Gazi University
• Years: 2009-2015

PhD/Medical Specialty

• Field: Department of Internal Medicine/Cardiology Department
• University: Mustafa Kemal University
• Years: 2016-2020

Experience:

General Practitioner

• Institution: Kırıkhan Community Health Center
• Years: 2015-2016

Research Assistant Doctor

• Institution: Hatay Mustafa Kemal University Faculty of Medicine Cardiology Department
• Years: 2016-2020

Specialist Doctor

• Institution: Hatay Training and Research Hospital
• Years: 2020-2022

Doctor Academic Staff

• Institution: Hatay Mustafa Kemal University Faculty of Medicine Cardiology Department
• Years: 2022-2024
•  

Prof. Cengiz KÖKSAL, M.D.

Cardiovascular Surgery

Areas of Expertise

• Minimally invasive mitral valve repair and replacement
• Off-pump (beating heart) mitral valve surgery
• Minimally invasive aortic valve replacement
• Minimally invasive coronary bypass surgery
• Carotid (neck artery) surgery
• Aesthetic varicose vein surgery
• Non-surgical treatment of arterial/venous aneurysms in the legs

Education

• Primary Education – Afyon, Turkey
• Secondary & High School – Darüşşafaka High School, Graduated as Top of Class
• M.D., Doctor of Medicine – Istanbul University, Istanbul Faculty of Medicine, 1992
• Specialization in Cardiovascular Surgery – Cerrahpaşa Faculty of Medicine, Istanbul University (1992–1998)

Career

• Cardiovascular Surgeon – Süreyyapaşa Chest, Heart and Vascular Diseases Hospital (2001–2007)
  • Contributed to the foundation of the Cardiovascular Surgery Clinic
  • Achieved Associate Professor title in 2005
• Senior Surgeon – Kartal Koşuyolu High Specialization Training and Research Hospital (2007 onward)
  • Appointed Deputy Chief of Cardiovascular Surgery in 2009
  • Clinical Educator from 2011 to 2017
  • Performed over 2,000 open-heart and vascular surgeries
  • Education Supervisor of the Cardiovascular Surgery Clinic (2016–2017)
• Professor – Bezmialem Vakıf University, Faculty of Medicine (2017–2024)
  • Head of Cardiovascular Surgery Department
• Current Position – Medipol University, Medipol Acıbadem Regional Hospital (Since July 2024)

International Training and Grants

• Leonardo da Vinci EU Scholarship Winner, Portugal (2012)
• Advanced trainings in minimally invasive mitral valve surgery (without sternotomy or heart-lung machine) conducted in:
  • Israel, Portugal, United Kingdom, Italy, Germany (2012–2016)

Achievements & Honors

• "Physician of the Year", Ibn Sina 1000th Year Medical Awards (2018)
• Only physician in Turkey authorized to educate and practice off-pump mitral valve repair
• Organizer of annual Mitral Valve Repair Workshops with national and international participation
• President, National Vascular and Endovascular Surgery Association (2016–2018)
• Editor, the most comprehensive vascular surgery textbook published in Turkish

Academic Contributions

• 80+ peer-reviewed international scientific articles
• 75+ national publications
• Authored 4 book chapters

Delivered 

200+ presentations

 in national and international conferences (since 2011)

• AREAS OF INTEREST
• Spine surgery
• Scoliosis
• Kyphosis
• Childhood spinal diseases
• Degenerative spine diseases
• Lumbar cervical disc herniation
• Knee hip joint disorders
• Orthopedic trauma surgery

• Education and Specialization
• 2010 - Cerrahpasa Faculty of Medicine - Medical Education
• 2016 - Medeniyet University Goztepe Training and Research Hospital - Specialization

• Experience
• 2016 - 2022 - Sisli Hamidiye Etfal Training and Research Hospital
• 2015 -2016 - Chicago Loyola University, Illinois, USA

• Courses and Certificates
• 13.12.2019-14.12.2019 Turkish Spine Society Eurospine Accredited Education Modules
• 08.11.2019-10.11.2019 Turkish Spine Society Eurospine Accredited Education Modules
• 31.08.2015-04.09.2015 Basic Microsurgery Course, MICROSURGERY EDUCATION-RESEARCH LABORATORY
• AO Trauma Course-Basic Principles of Fracture Management
• 07.06.2014-10.06.2014 Fracture Management, Kodi Kojima Chairperson AOTrauma Education Commission
• 01.03.2013-02.03.2013 Instrumentation in Arthroscopic Surgery

• Professional Memberships
• Turkish Orthopedics and Traumatology Association (TOTBİD)
• Turkish Medical Association - Istanbul Medical Chamber

In 2007 he joined the Costa del Sol Hospital and left this position when he obtained an international scholarship that would take him back to San Francisco. In 2010 he moved to Japan to complete his training in the submucosal endoscopic dissection technique that he would later on introduce in Andalusia in 2011, thus becoming one of the pioneers in the performance of this technique in Spain. In 2011 he became the first medical professional in the world to use the 15-mm AXIOS stent in pancreatic fluid collection drainage. In 2018 he began to perform gastroenteroanastomosis with luminal apposition stent in patients with pancreatic cancer and bowel obstruction, thus becoming a pioneer in Andalusia to perform such technique.

He is a coauthor of the reference guides of the European Society of Gastrointestinal Endoscopy on the endoscopic treatment of chronic pancreatitis and non-variceal gastrointestinal haemorrhage.

Professional Experience

Over 24 years' experience

1999 - Degree in Medicine and Surgery. Malaga University, Spain.

2003 to 2006 - Medical Residency in the Digestive System at the Virgen Macarena Hospital in Seville, Spain.

2006 - International Scholar at the California Pacific Medical Center in San Francisco, USA.

2007 – Digestive System Specialist at the Costa del Sol Hospital, Marbella. Spain.

2008 - California Pacific Medical Center in San Francisco, USA.

2009 - Top Reviewer Award received from the Gastrointestinal Endoscopy Journal.

2011 – Pioneer in Spain in the introduction of the submucosal endoscopic dissection technique.

2011 – First professional in the world to use the AXIOS (15mm) stent for pancreatic fluid collection drainage.

2016 - Gold Medal of the Andalusian Society for Digestive Disease (SAPD, in its Spanish abbreviation).

2017 - Fellow of the American College of Gastroenterology (FACG).

2018 - Pioneer in Andalusia to perform gastroenteroanastomosis with luminal apposition stent to treat bowel obstruction.

2019 - Fellow of the American Society for Gastrointestinal Endoscopy (FASGE).

The Digestive System Unit of the Quirónsalud Marbella Hospital offers a patient service portfolio that includes all the clinical aspects of gastroenterology, hepatology, biliary duct and pancreatic disease, as well as the diagnostic and treatment techniques used in this speciality such as abdominal ultrasound, endoscopy and other functional tests.

Our specialists have solid professional backgrounds and the team is highly qualified for the diagnosis and treatment of complex diseases such as conditions related to acidity (gastric ulcers, helicobacter pylori, gastroesophageal reflux disease), enteropathies (Crohn's Disease, ulcerative colitis; coeliac disease...), viral hepatitis, hepatic cirrhosis, pancreatic disease...

The Digestive System Unit of the Quirónsalud Marbella Hospital is a pioneer in the implementation of a specific check-up programme for digestive disease with special attention to the diagnosis and treatment of colon precancerous lesions.

Diseases, treatments and techniques:

• Diagnostic and therapeutic endoscopic ultrasound

• Endoscopic resection techniques (mucosectomy/submucosal dissection)

• Submucosal or third-space endoscopy (POEM and variants)

• Bariatric endoscopy (Apollo Method)

He is an expert in cardiac arrhythmia, pacemaker implantation, internal defibrillators and catheter ablation; and he conducts diagnostic electrophysiological studies.

He also carries out extensive teaching work as a Senior Lecturer of the Medicine Department of the Malaga University, where he teaches the subject Diseases of the Circulatory and Respiratory Systems to fourth-year medical students.

He is the author of over 100 scientific publications in influential journals. At the same time, he has contributed to the preparation of clinical practice guides and is the author of 23 books and chapters of scientific titles in the speciality.

Professional experience

University Degree in Medicine and Surgery (1978) obtained at the Zaragoza University.

Degree as Doctor in Medicine by the Zaragoza University with final thesis “Cardiac Automatism and Conduction in a Model of Experimental Heterotopic Cardiac Transplantation. Effects of Verapamil”, which obtained a cum laude award.

Training as a Resident Doctor in Cardiology at Clínica Puerta de Hierro in Madrid (1979-1984).

Cardiology Medical Consultant and the Head of the Arrhythmia Unit at Clínica Puerta de Hierro (1985-1992).

Other positions:

Coordinator of the Implantable Defibrillator working team of the Spanish Cardiology Society (2009 – 2016).

Member of the European Society of Cardiology.

Member of the European Heart Rhythm Association.

Member of the Spanish Cardiology Society.

Member of the Andalusian Cardiology Society.

Member of the Editorial Committee of the Spanish Cardiology Journal.

Member of the Editorial Committee of Cardiocore.

Member of the Editorial Committee of Cardiac Stimulation Notebooks.

The Cardiology Unit of Quirónsalud Marbella Hospital is made up of a medical team with large experience in the diagnosis and treatment of heart diseases, as well as employing the most advanced technologies, both in the clinical area and in the area of haemodynamics and arrhythmia.

Diseases, treatments and techniques:

• Clinical cardiology

- Adult and children cardiology consultation with the performance of supplementary tests, all within one appointment.

- Specific consultations for arrhythmia

- Paedriatic cardiology

- Colour Doppler echocardiography and stress echocardiography

- Stress test

- 24-hour and long-term Holter EKG

- CT coronary angiogram

- Cardiac magnetic resonance imaging (MRI)

- Tilt table testing

- Cardiac rehabilitation

Cardiac haemodynamics

- Diagnostic cardiac catheterisation and percutaneous treatment of ischaemic heart disease with angioplasty and stent implant

- Myocardial infarction percutaneous treatment programme

- Transcatheter aortic valve implantation (TAVI)

- Percutaneous repair of the mitral valve (Mitral clip)

- Percutaneous closure of interatrial communication

- Percutaneous closure of left atrial appendage

Arrhythmia Unit 

- Diagnostic electrophysiological study 

- Catheter ablation

 - Cryoablation of atrial fibrillation

 - Ablation using a complex arrhythmic substrate navigator

 - Pacemaker implantation 

- Automatic endovenous and subcutaneous implantable

defibrillator

Cardiac surgery 

- Surgery with and without extracorporeal circulation

- Minimally-invasive surgery with an early extubation

• - Repair of mitral and aortic valves

EDUCATION:

2000 - SSK Okmeydanı Training and Research Hospital, .

1996 - Istanbul University, Istanbul Faculty of Medicine

EXPERIENCE:

2019 - Istanbul Medipol University Pendik Hospital

2017 - 2019 - Private Adatıp Kurtköy Hospital

2005 - 2017 - Private Avicenna Umut Hospital

2003 - 2005 - SSK Yalova Regional Hospital

2002 - 2003 - Kayseri Military Hospital

Education

• 2002 - 2008, Ege University, Bachelor's Degree, Medical Doctor
• 2009 - 2013, Istanbul Bagcilar Training and Research Hospital, Specialization in Cardiology
• 2013 - 2018, Bezm-i Âlem Vakif University, Assistant Professor
• 2018 – 2021, Bezm-i Âlem Vakif University, Associate Professor

Experience

• 2009 - 2013, Istanbul Bagcilar Training and Research Hospital
• 2013, Istanbul Esenler Basaksehir State Hospital
• 2014, Bursa Mustafakemalpasa State Hospital
• 2013 – 2014, Ministry of Health Mehmet Akif Ersoy Hospital
• 2014 – 2016, Mustafakemalpasa State Hospital, Bursa
• 2016 – 2024, Bezm-i Âlem Vakif University
• 2024 – Present, Medipol Acibadem Hospital

Dr Romero Imbroda is an academic of the Royal Academy of Medicine of Eastern Andalusia and a Fellow of the European Board of Neurology, as well as a Member of the Board of Directors of the

Andalusian Society of Neurology. He combines his medical practice with his teaching role at the University of Granada, where he is a Lecturer and has been a Member of the Internal Residential Doctor Assessment Committee in Melilla until 2017.

He is the author of several national and international scientific publications. He has also participated in research projects associated with treatments for multiple sclerosis.

Professional Experience:

• 2020: President of the Andalusian Society of Neurology

• 2019: Head of the Units at the Quirónsalud Malaga and Marbella Hospitals

• 2017-2021: Neurologist at the Regional Malaga University Hospital.

• 2016-2017: Lecturer at the University of Granada.

• 2009-2017: Neurologist at the Imbrain Neuroscience Clinic. Melilla.

• 2009-2017: Neurologist at the Melilla Hospital.

• 2008-2009: Neurologist at the Virgen de las Nieves Hospital. Granada.

• 2004-2008: Neurologist at the Carlos Haya Hospital. Malaga.

Academic Training:

• 2017: Innovation and Leadership in Neurology. Business Institute. Madrid.

• 2014: Educational Commission for Foreign Medical Graduates. United States.

• 2011-2012: Management of Integrated Health Services. ESADE. Madrid.

• 2010: Neurologists for the Future. Spanish Neurology Society.

• 2010: Master in Tissue Engineering. University of Granada.

• 2010: Doctorate at the University of Granada. Summa Cum Laude. 2010.

• 2004-2008: Neurology specialist at the Carlos Haya Hospital. Malaga.

• 1997-2003: University Graduate in Medicine at the University of Granada.

The Neurology Unit of the Quirónsalud Marbella Hospital specialises in the study and treatment of conditions associated to the nervous system, the brain, the spinal cord, the peripheral nerves and the muscles. We have the most advanced technology that enables us to make accurate and personalised diagnoses and treatments in the study of patients with complex diagnoses and treatments (MRI, CT scan,electroencephalogram, transacranial doppler ultrasound, cerebral arteriogramand neuropschycological testing).

We offer our patients highly-specialised treatments for cerebrovascular and neuromuscular diseases, Parkinson's Disease, headaches and migraine, epilepsy, multiple sclerosis, peripheral neuropathies, infections of the nervous system, movement disorders, dementia and other cognitive conditions, paediatric neurology, sleep disorders, tumours and complications deriving from injuries to the spine and the head.

Prof. Dr. Önder SÜRGİT is a General Surgeon in the General Surgery Clinic. Working hours: 09:00–18:00. Core practice areas include laparoscopic surgery, cancer surgery, and bariatric surgery.

Graduated from Hacettepe Faculty of Medicine in 1995. Academic title: Professor. Served as Instructor Surgeon at ITEM (Advanced Medical Technologies Training Center). Held faculty roles at Turgut Özal University and Atılım University, Faculties of Medicine. Also worked at Ankara Medicana Hospital and Optimed Health Group. Foreign language: English.

Prof. Dr. Mehmet Sait Buğdacı is a highly experienced physician specializing in Internal Medicine and Gastroenterology. He completed his medical education and specialty training at Istanbul University Cerrahpaşa Faculty of Medicine and Şişli Etfal Training and Research Hospital. His clinical interests include gastrointestinal diseases, endoscopic procedures, and clinical research. He has contributed to medical education through numerous scientific publications and textbooks and currently sees patients at Central Hospital.

Areas of Interest • Pediatric gastrointestinal surgery • Anorectal malformations and motility disorders • Minimally invasive pediatric surgery • Pediatric colorectal and pelvic floor disorders

Dr. Ugur Taskin is a specialist in interventional cardiology. He treats conditions such as high cholesterol, heart valve diseases, heart failure, and coronary artery disease. He received his medical degree from Ankara University Faculty of Medicine.

Dr. Taskin worked at Celal Bayar University Faculty of Medicine from 2009 to 2014, where he gained valuable experience. He is a member of the Turkish Society of Cardiology and the Izmir Medical Chamber. These memberships show his dedication to high standards in cardiology.

Dr. Baha Zengel is a general surgeon with expertise in breast, gallbladder, thyroid diseases, and hernia repairs. He graduated from Ege University Faculty of Medicine in 1990. In 2004, he earned a doctorate in Basic Oncology from Dokuz Eylül University. He became an Associate Professor of General Surgery in 2014 through the Inter-University Board.

Dr. Zengel is skilled in advanced surgical procedures. His experience includes skin and breast-conserving mastectomy, oncoplastic breast surgery, laparoscopic cholecystectomy, sentinel lymph node biopsy, and ROLL/SNOLL techniques. He has held important positions at Izmir Bozyaka Training and Research Hospital, including Education Officer.

He is a member of several professional associations. He serves on the Board of Directors of the Aegean Region Surgery Association and is a founding board member of the Basic Oncology Association.